Richard A. Heyman's Net Worth
$4.97 Million
Who is Richard A. Heyman?
Richard A. Heyman has an estimated net worth of $4.97 Million. This is based on reported shares across multiple companies, which include Enliven Therapeutics, Inc., Receptos, Inc., PMV Pharmaceuticals, Inc., Gritstone bio, Inc., BCTG Acquisition Corp., ORGANOVO HOLDINGS, INC., Metacrine, Inc., Oric Pharmaceuticals, Inc., YUMANITY THERAPEUTICS, INC., and RayzeBio, Inc..
SEC CIK
Richard A. Heyman's CIK is 0001584759
Past Insider Trading and Trends
2021 was Richard A. Heyman's most active year for acquiring shares with 10 total transactions. Richard A. Heyman's most active month to acquire stocks was the month of May. 2021 was Richard A. Heyman's most active year for disposing of shares, totalling 27 transactions. Richard A. Heyman's most active month to dispose stocks was the month of May. 2021 saw Richard A. Heyman paying a total of $959,253.75 for 94,898 shares, this is the most they've acquired in one year. In 2015 Richard A. Heyman cashed out on 26,200 shares for a total of $3,619,376.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Enliven Therapeutics, Inc. (ELVN) Snapshot price: $15.51
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.03% | -6.96K |
$23.34 | -$167,887.52 | 165.86K |
Scheduled
|
Apr 11 - Apr 15
| ||
Form 4
| -0.88% | -1.27K |
$14.50 | -$18,418.68 | 143.47K |
Scheduled
|
Mar 19
| ||
Form 4
| -0.87% | -1.27K |
$17.42 | -$22,117.43 | 144.74K |
Scheduled
|
Feb 15
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
| -0.86% | -1.27K |
$16.41 | -$20,839.56 | 146.01K |
Scheduled
|
Jan 30
| ||
Form 4
| -0.12% | -216.00 |
$13.00 | -$2,808.00 | 176.5K |
Scheduled
|
Dec 21 - Dec 22
| ||
Form 4
| -2.36% | -4.28K |
$13.02 | -$55,727.05 | 176.71K |
Scheduled
|
Dec 19 - Dec 20
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
|
∞
| 218.4K |
—
|
—
| 218.4K |
Feb 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Receptos, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -7.40K |
—
|
—
|
0
|
Aug 27
| |||
Form 4
|
∞
| 7.4K |
—
|
—
| 7.4K |
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PMV Pharmaceuticals, Inc. (PMVP) Snapshot price: $1.725
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
$139.26 | $832,318.28 |
0
|
Scheduled
|
Jun 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Gritstone bio, Inc. (GRTS) Snapshot price: $2.14
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
BCTG Acquisition Corp. (TNGX) Snapshot price: $12.73
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |